NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.04% |
| UCB | UCB SA | Healthcare | Biotechnology | 4.39% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 4.06% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.03% |
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 3.95% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.85% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.50% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.30% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.14% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.64% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 2.62% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 2.57% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.52% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.42% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.33% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 2.18% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.12% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 1.91% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.83% |